Swine Flu is big business

The soap giant Cussons will be absolutely delighted with the panic surrounding swine flu with sales of their antibacterial gels soaring in the past few months. They are not the only ones to benefit; the inventor of Tamiflu has made millions as his product is the sole medication on the market. GlaxoSmithKline have also been accused of cashing in on the virus after charging the NHS £6 for a swine flu vaccine which costs £1 to make.

This is a brilliant topic for talking about supply and demand and the affect of a monopoly on prices. Click on the links for three separate articles.